Betalin Therapeutics's diabetes treatment aims to replace insulin therapy for millions of patients. It created a completely natural biological micro-scaffold, providing an optimal environment for cells to grow and function properly. With this combination of the harvested cells and the proprietary micro-environment called Engineered Micro-Pancreas, fewer cells will be required for each transplant. More than 5 times as many patients can be treated from the same number of harvests and significantly lowering the cost. Transplants will be more successful because harvested cells thrive in the micro-environment of EMPs and in turn, integrate into the recipient's body much more readily. It will also be more effective as the insulin secreted from EMPs is better regulated and longer-lasting than insulin from islets alone.